• Tue, December 9, 2014
  • Wed, December 10, 2014
  • Fri, December 12, 2014
  • Thu, December 11, 2014

Jessica Fye Maintained (BCRX) at Buy with Decreased Target to $18 on, Dec 9th, 2014

Jessica Fye of JP Morgan, Maintained "BioCryst Pharmaceuticals, Inc." (BCRX) at Buy with Decreased Target from $20 to $18 on, Dec 9th, 2014.

Jessica has made no other calls on BCRX in the last 4 months.



There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, 0 agree with Jessica's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jessica


  • Tazeen Ahmad of "B of A Securities" Maintained at Sell with Decreased Target to $8 on, Thursday, December 4th, 2014

Like: 👍